You have 9 free searches left this month | for more free features.

apatinib

Showing 1 - 25 of 208

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed Ovarian Cancer Trial (Fluzoparib, Apatinib)

Not yet recruiting
  • Relapsed Ovarian Cancer
  • (no location specified)
Oct 7, 2023

Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

Recruiting
  • Digestive System Cancers
  • Beijing, China
    Peking University Cancer Hospital
Oct 25, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 3, 2023

Gastric Cancer Trial in Tianjin (AK104, Apatinib, Paclitaxel)

Recruiting
  • Gastric Cancer
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
May 7, 2023

Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Apatinib
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Breast Cancer Metastatic Cancer Trial in Shanghai (Apatinib, Dalpiciclib, Fulvestrant/AI)

Recruiting
  • Breast Cancer Metastatic Cancer
  • Apatinib
  • +2 more
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Feb 26, 2023

Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)

Not yet recruiting
  • Immunotherapy Gastrict Cancer
  • (no location specified)
Jan 17, 2023

Cholangiocarcinoma Trial (Carrilizumab, Albumin-bound paclitaxel, Apatinib)

Not yet recruiting
  • Cholangiocarcinoma
  • (no location specified)
Dec 9, 2022

Hepatocellular Carcinoma Trial in Nanjing (Camrelizumab, TACE, Apatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Nanjing, Jiangsu, China
    Zhongda Hospital
Sep 8, 2022

Cancer Trial in Santa Monica (Apatinib, Nivolumab)

Active, not recruiting
  • Cancer
  • Santa Monica, California
    Sarcoma Oncology Research Center
May 19, 2022

Triple Negative Breast Cancer Trial in Chengdu (Camrelizumab, Apatinib, Nab-paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Jul 6, 2022

Thyroid Cancer Trial in Peking (Apatinib)

Completed
  • Thyroid Cancer
  • Apatinib
  • Peking, China
    Peking Union Medical College Hospital
Jan 18, 2022

Gastric Cancer Trial in Shanghai (Apatinib)

Completed
  • Gastric Cancer
  • Apatinib
  • Shanghai, Shanghai, China
    Shanghai 6th People's Hospital
Feb 24, 2022

Hepatocellular Carcinoma Trial in Guangzhou (FOLFOX-HAIC, Camrelizumab, Apatinib)

Recruiting
  • Hepatocellular Carcinoma
  • FOLFOX-HAIC
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Jan 19, 2022

Esophageal Tumors Trial (Apatinib, The chemotherapeutic drug chosen by the investigator.)

Withdrawn
  • Esophageal Neoplasms
  • Apatinib
  • The chemotherapeutic drug chosen by the investigator.
  • (no location specified)
Apr 11, 2022

Gastric Cancer Trial in Xining, Yangquan (Apatinib)

Completed
  • Gastric Cancer
  • Apatinib
  • Xining, Qinghai, China
  • +4 more
Mar 14, 2022

NSCLC Trial in Wuhan (Apatinib)

Enrolling by invitation
  • NSCLC
  • Apatinib
  • Wuhan, Hubei, China
    Hubei Cancer hospital
Feb 4, 2022

Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma Trial in Zhengzhou, Nanjing (SHR-1210, Apatinib, FOLFOX4)

Active, not recruiting
  • Advanced Primary Liver Cancer
  • Advanced Biliary Tract Carcinoma
  • SHR-1210
  • +3 more
  • Zhengzhou, Henan, China
  • +1 more
Apr 26, 2022

NSCLC Trial in Wuhan (Camrelizumab, Apatinib, Docetaxel injection)

Recruiting
  • Non-Small Cell Lung Cancer
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Apr 29, 2022

Gastric Cancer Trial in Jinan (SHR1210, Apatinib, S1)

Recruiting
  • Gastric Cancer
  • Jinan, Shandong, China
    Qilu hospital of Shandong univertisy
Mar 30, 2022

Breast Cancer Trial in Shanghai (Apatinib, Paclitaxel, Cisplatin)

Recruiting
  • Breast Cancer
  • Apatinib
  • +3 more
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Dec 18, 2021

Triple-Negative Breast Cancer Trial in Guangzhou (Apatinib)

Completed
  • Triple-Negative Breast Cancer
  • Apatinib
  • Guangzhou, Guangdong, China
  • +1 more
Jan 29, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Apatinib, Camrelizumab, NK cell)

Recruiting
  • Hepatocellular Carcinoma
  • Apatinib
  • +2 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital of Southern Medical University
Dec 26, 2021

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (Camrelizumab, Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Guangzhou, Guangdong, China
    Li Xu
Dec 8, 2021

Gastric Cancer, GastroEsophageal Cancer Trial in China (SHR-1210, Capecitabine, Oxaliplatin)

Completed
  • Gastric Cancer
  • GastroEsophageal Cancer
  • SHR-1210
  • +3 more
  • Hefei, Anhui, China
  • +9 more
Jun 30, 2022